A Clinical Efficacy and Safety Study of OHB-607 in Preventing Bronchopulmonary Dysplasia in Extremely Premature Infants

NCT03253263 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

338

Enrollment

INDUSTRY

Sponsor class

Conditions

Bronchopulmonary Dysplasia
Chronic Lung Disease of Prematurity
Intraventricular Hemorrhage
Retinopathy of Prematurity (ROP)

Interventions

DRUG: OHB-607

Sponsor

OHB Neonatology Ltd.